Company

Creso Pharma Limited

Headquarters: Nedlands, WA, Australia

CEO: Mr. William Lay B.Com.

ASX: CPH

Market Cap

A$5.1 Million

AUD as of Jan. 1, 2024

US$3.5 Million

Market Cap History

Creso Pharma Limited market capitalization over time

Evolution of Creso Pharma Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Creso Pharma Limited

Detailed Description

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Creso Pharma Limited has the following listings and related stock indices.


Stock: ASX: CPH wb_incandescent

Stock: OTC: COPHF wb_incandescent

Details

Headquarters:

145 Stirling Highway

Suite 5 CPC 300 Barangaroo Avenue Barangaroo

Nedlands, WA 6009

Australia

Phone: 61 8 9389 3100

Fax: 61 8 9389 3199